483
Kite Pharma, Inc.Kite Pharma, Inc. – FDA 483, Aug 20, 2019
Record Details
Kite Pharma Inc. in El Segundo, CA, was cited with three observations during an FDA inspection of its biologic cell therapy facility. The observations relate to deficiencies in establishing the accuracy of test methods, failure to report biological product deviations within the required timeframe, and not following written production and process control procedures. These issues indicate a lack of robust quality control and adherence to established protocols in their manufacturing operations.
View Company Profile
ID · 72dcf3ed-0f1a-4b13-b8ac-1c8599f6c7a2
Other documents for Kite Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.